Clinical Trials Logo

Filter by:
NCT ID: NCT00487539 Completed - Colitis, Ulcerative Clinical Trials

An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis

Start date: August 2007
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to assess the effects (good and bad) of golimumab (CNTO 148) therapy in participants with ulcerative colitis (UC).

NCT ID: NCT00487370 Completed - Clinical trials for Osteoarthritis, Knee

Implantation of Gold Beads to Relieve Discomfort From Knee Osteoarthritis

Start date: March 1997
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether implanting gold beads extraarticularly in five acupuncture-points around a knee improves pain, stiffness and function in patients with knee osteoarthritis.

NCT ID: NCT00486434 Completed - Osteoarthritis Clinical Trials

Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis

Start date: May 2007
Phase: Phase 3
Study type: Interventional

The purpose of this Phase III study is to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of patients with osteoarthritis of the knee.

NCT ID: NCT00486369 Completed - Osteoarthritis Clinical Trials

SMC021A - Absorption, Efficacy and Tolerance in Patients With Osteoarthritis. A Placebo-Controlled 14-Days Study

Start date: January 2007
Phase: Phase 1
Study type: Interventional

The purpose of this study is to expose patients with OA to calcitonin and to determine plasma calcitonin levels after administration of 0.6 mg and 0.8 mg oral calcitonin. Also the purpose is to assess the effect of different doses of oral calcitonin (0.6 mg and 0.8 mg oral) compared to placebo on serum CTX-I and CTX-II. Finally to assess the tolerance profile of different doses/formulations of oral calcitonin compared to placebo.

NCT ID: NCT00486317 Completed - Osteoarthritis Clinical Trials

Pharmacokinetics/Pharmacodynamics of Oral Salmon Calcitonin in Patients With Osteoarthritis

Start date: October 2005
Phase: Phase 1
Study type: Interventional

The purpose of this study is to expose patients with OA to calcitonin and to determine plasma calcitonin levels after administration of 0.6 mg and 0.8 mg oral calcitonin and 200 IU nasal calcitonin. Also the purpose is to assess the effect of different doses of oral calcitonin (0.6 mg and 0.8 mg oral) and 200 IU nasal calcitonin compared to placebo on serum CTX-I and CTX-II. Finally to assess the tolerance profile of different doses/formulations of oral calcitonin compared to placebo.

NCT ID: NCT00485212 Completed - Clinical trials for Total Knee Arthroplasty

Compression Bandage in Local Infiltration Analgesia Afte Total Knee Arthroplasty

Start date: January 2007
Phase: Phase 4
Study type: Interventional

purpose: to determine wether a compression bandage prolongs analgesia of local infiltration analgesia after total knee arthroplasty

NCT ID: NCT00484302 Completed - Schizophrenia Clinical Trials

Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis

CapOpus
Start date: September 2007
Phase: N/A
Study type: Interventional

The purpose of the trial is to investigate the effect of specialized treatment of cannabis abuse among young people with psychosis. The specialized treatment consists of manualized individual treatment and group therapy. It will be compared with the standard treatment, which consists of non-specialized, non-manualized treatment. 140 patients will be randomised to one of the two treatments, and the investigator(s) will be blinded to the treatment received.

NCT ID: NCT00483730 Completed - Clinical trials for Symptomatic Diabetic Peripheral Polyneuropathy

Actovegin® Versus Placebo in Patients With Diabetic Polyneuropathy (AV-007-IM)

Start date: December 2006
Phase: Phase 3
Study type: Interventional

To assess clinical efficacy and safety of Actovegin in type 2 diabetic patients with symptomatic diabetic peripheral polyneuropathy after 250 ml i.v. infusions once daily for 20 days followed by oral treatment 600 mg × 3 daily for 140 days.

NCT ID: NCT00483145 Completed - Clinical trials for Acne Vulgaris and Rosacea

Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea

Start date: November 2006
Phase: N/A
Study type: Interventional

To evaluate efficacy and adverse effect from long-pulsed dye laser versus long-pulsed dye laser-mediated photodynamic therapy for acne vulgaris and rosacea.

NCT ID: NCT00482664 Completed - Clinical trials for Sexual Dysfunction, Physiological

The Efficacy, Safety And Toleration Of CP-866,087 In Pre-Menopausal Women With Female Sexual Arousal Disorder.

Start date: July 2007
Phase: Phase 2
Study type: Interventional

CP-866,087 is a non-hormonal compound, acting on the central nervous system, which has been shown in animal models to restore sexual function.